Nelson Vergel, the founder of ExcelMale.com, ClinicOptimizers.com and DiscountedLabs.com, interviews Dr. Richard Walker about the history of research on GHRH and GHRPs.
Richard F. Walker, Ph.D., R.Ph is well known for having popularized Sermorelin, a growth hormone-releasing hormone. He received a BS in pharmacy from Rutgers University, an MS in biochemistry from New Mexico State University and a Ph.D. in physiology from Rutgers University. He completed an internship in neuroanatomy/electrophysiology at Emory University College of Medicine, and postdoctoral fellowships in neuroendocrinology and neuropharmacology at Duke University College of Medicine (Center for the Study of Aging and Human Development) and the University of California, Berkeley, respectively. Dr. Walker held tenured faculty positions at Clemson University (Department of Zoology) and the University of Kentucky, College of Medicine (Department of Anatomy and Molecular Biology/Sanders-Brown Research Center on Aging). He left academia for a brief hiatus in the pharmaceutical industry serving as Director of Toxicology at SmithKline Beecham Pharmaceutical Corp. At the same time, he was also a research professor in the Department of Pharmacology at the Medical College of Pennsylvania and later at the University of South Florida (USF) College of Medicine. In addition to his research duties at USF, Walker served as Director for Research Compliance and also Director of USF CARES (Clinical Alliance for Research, Education, and Service). He has been the recipient of many federal (NSF, NIH, DOD), state and local research grants and has published extensively towards understanding the cause of senescence and treating functional deficits associated with organismal aging. Walker is currently Editor-in-Chief of Clinical Interventions in Aging, a source of evidence-based information for practitioners of age-management medicine published by Dove Medical Press and author of the book, “Why We Age: Insight into the cause of growing old” He is partner in ProSoma LLC which manufactures and distributes anti-aging products, and he also heads a private consulting company offering regulatory and scientific services to physicians and other health-care professionals.
Recent Posts
A Doctor Speaks: Who is a Candidate for Testosterone Replacement Therapy?
Who is a Candidate for Testosterone Replacement Therapy?
By Abraham Morgentaler, M.D.
There is consensus that candidates for treatment with Testosterone Replacement Therapy should have signs...
ED Drugs Have Benefits Beyond Treating Erectile Dysfunction
It’s been 18 years since the FDA approved sildenafil to treat men suffering from erectile dysfunction (ED). Under the well-known brand name Viagra, this...
Is Clomid (Clomiphene) Effective to Increase Testosterone, Fertility and Sperm Volume?
I am trying to save many of you time in searching important information in key posts. Here is a list of good posts related...
How to Convert mmol/L to mg/dl or pg/mL (or viceversa) of Different Hormones
Since we have members on this site that live outside the United States (where we use mg, pg, etc instead of mmol,micromoles, etc), we...
Responses of Different Doses of Testosterone Injections on Body Composition, Strength, etc.
Comment: 125 mg per week was the lowest dose that provided statistically significant changes in lean body mass and fat mass.
PAPER ATTACHED
Testosterone dose-response relationships...